Skip to main content

Precision Medicine: Patent and Regulatory Frameworks in Canada

October 7, 2014

In the October/November issue of Biotechnology Focus, Carmela De Luca and Amy Dam write about “precision medicine” and provide a review of some Canadian-specific scenarios under the current legal regimes that may influence development of its technologies.

Content shared on Bereskin & Parr’s website is for information purposes only. It should not be taken as legal or professional advice. To obtain such advice, please contact a Bereskin & Parr LLP professional. We will be pleased to help you.

Author(s):

Carmela De Luca Carmela De Luca
B.Sc. (Hons. Biochem., Co-op), Ph.D. (Exp. Med.), J.D.
Partner
514.871.2929  email Carmela De Luca
Amy Dam Amy Dam
B.Sc. (Biomed. Sci.), M.Sc. (Pharm.), LL.B.
Associate
514.871.2350  email Amy Dam